Dyne Therapeutics Stock Target Price and Analyst Consensus
| DYN Stock | USD 14.14 0.60 4.43% |
The current analyst and expert consensus on Dyne Therapeutics is Strong Buy, with 7 strong buy opinions. The current projected Dyne Therapeutics target price consensus is 50.83 with 12 analyst opinions. Check out Macroaxis Advice on Dyne Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.The most common way Dyne Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Dyne Therapeutics executives and customers to further validate their buy or sell advice. Dyne Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Dyne Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 5.7461.
Lowest Forecast 46.26 | Highest Forecast 56.42 | Target Price 50.83 |
Dyne |
It's important to approach Dyne Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Dyne Therapeutics Target Price Consensus
Dyne target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Dyne Therapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 12 | Strong Buy |
Most Dyne analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Dyne stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Dyne Therapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationDyne Therapeutics Target Price Projection
Dyne Therapeutics' current and average target prices are 14.14 and 50.83, respectively. The current price of Dyne Therapeutics is the price at which Dyne Therapeutics is currently trading. On the other hand, Dyne Therapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Dyne Therapeutics Market Quote on 31st of January 2025
Target Price
Analyst Consensus On Dyne Therapeutics Target Price
Dyne Therapeutics Analyst Ratings
Dyne Therapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Dyne Therapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Dyne Therapeutics' financials, market performance, and future outlook by experienced professionals. Dyne Therapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Dyne Therapeutics price targets
Dyne Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Dyne Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Dyne Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Dyne Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Dyne Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Dyne Therapeutics is a key component of Dyne Therapeutics valuation and have some predictive power on the future returns of a Dyne Therapeutics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Dyne Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Automobiles and Trucks Invested over 300 shares | |
 | Hedge Favorites Invested over 50 shares | |
 | Blockchain Invested few shares | |
 | Banking Invested over 30 shares | |
 | Investor Favorites Invested over 60 shares | |
 | Macroaxis Index Invested few shares | |
 | Power Assets Invested over 300 shares | |
 | Warren Buffett Holdings Invested over 60 shares | |
 | Momentum Invested over 50 shares | |
 | Driverless Cars Invested over 300 shares | |
 | Chemicals Invested over 30 shares | |
Check out Macroaxis Advice on Dyne Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.